Skip to main content
. Author manuscript; available in PMC: 2021 Apr 1.
Published in final edited form as: Ann Surg Oncol. 2020 Jan 8;27(4):1013–1022. doi: 10.1245/s10434-019-08165-2

Table 1.

Patient demographic and clinical characteristics (n=289)

Characteristic No. (%)a
Local therapy
 Lump+WBI 108 (37.4)
 Lump+Brachy 103 (35.6)
 Lump alone 78 (27.0)
Age, years
 Median (range) 72 (67–87)
 67–74 200 (57.5)
 ≥75 89 (42.5)
Patient-reported race
 White 250 (86.7)
 Non-white 39 (13.3)
Charlson Comorbidity Index
 0 197 (68.5)
 1 71 (24.8)
 2+ 21 (6.6)
Patient-reported baseline BMI
 Underweight / Normal 93 (35.7)
 Overweight 77 (21.9)
 Obese 103 (34.8)
 Unknown 16 (7.7)
Patient-reported current bra cup size
 A-B 89 (31.0)
 C 88 (31.4)
 D+ 81 (25.8)
 Unknown 31 (11.8)
Axillary surgery
 Axillary dissection/axillary surgery NOS 94 (36.2)
 Sentinel lymph node biopsy 126 (45.7)
 No axillary surgery 69 (18.0)
Patient-reported endocrine therapy
 No 95 (39.5)
 Yes 194 (60.5)
Chemotherapy
 No 254 (84.7)
 Yes 35 (15.3)
Region
 Northeast 50 (22.2)
 Midwest 68 (20.8)
 South 119 (39.3)
 West or unknown 51 (17.7)
Patient-reported education
 High school or less 95 (32.9)
 Associate degree 97 (33.6)
 College or higher 82 (28.4)
 Unknown 15 (5.2)
Patient-reported current household income
 <$40K 120 (44.5)
 $40–60K 45 (12.5)
 >$60K 67 (22.8)
 Unknown 57 (20.2)
Has smoked 100 cigarettes in lifetime
 No 154 (53.8)
 Yes 119 (40.0)
 Unknown 16 (6.2)

Abbreviations: Lump+WBI = lumpectomy plus whole-breast irradiation; Lump+Brachy = lumpectomy plus brachytherapy; Lump alone = lumpectomy plus endocrine therapy alone; NOS = not otherwise specified.

a

All percentages are weighted percentages except for local therapy; weights accounted for differential selection and response rates.